For life sciences companies operating in a highly regulated industry, manual and paper-based document-management processes don’t produce the speed, accuracy, and consistency needed to achieve compliance and maintain a competitive edge. Since cumbersome document-centric processes impact virtually every area of a life sciences enterprise—from operations to data security and compliance—it makes sense to bring digital transformation to every facet of these processes.
However, not all digital transformation in life sciences is truly revolutionary. To fundamentally transform their enterprises, life sciences companies must adopt all-digital document-management solutions that address universal business challenges across the entire organization versus those that deliver a temporary, superficial boost to business outcomes at best.
Keep reading to learn how leading life sciences companies are eliminating manual intervention, improving business outcomes, and achieving their digital transformation goals by enriching their critical data and documents.
€15.9 Billion Pharma Company Curbs Submission Errors & Rising IT Costs with Adlib Enterprise
For a leading European pharmaceutical company, managing and maintaining a suite of 20+ disparate document-conversion solutions led to significant operational challenges, erroneous FDA submissions, and costly fines and delays. With a more streamlined approach in mind, the company adopted Adlib Enterprise as its primary document conversion solution of choice. Learn how this pharmaceutical organization was able to decommission 20+ rendering platforms, reduce operational costs, and significantly improve the quality and timeliness of its FDA submissions by adopting Adlib Enterprise.
Global Pharmaceutical Company Streamlines Internal Processes with Adlib Enterprise
For pharmaceutical companies who invest a considerable amount of time and money to developing life-saving health products, there’s no room for errors and delays during the submission process. However, for Adlib’s leading life sciences customer—one of the world's premier biopharmaceutical companies—onerous manual processes and lack of searchability meant that FDA submission documentation was produced with unreliable quality and great difficulty. Discover how this global pharmaceutical company eliminated steep fines, delays, and inflated IT costs by adopting Adlib Enterprise.
Life Sciences Manufacturing Company Maximizes Uptime & Achieves Compliance by Automating its Document-Centric Processes
For a multinational consumer goods manufacturing division of a life sciences organization, producing and managing vast volumes of compliance documentation was stalling production times, monopolizing critical knowledge workers, and preventing the organization from reaching its digital transformation goals. The company recognized the need to automate their labor-intensive document-management processes, so they turned to Adlib. Learn how Adlib helped this enterprise increase the speed and volume of its document processing tenfold—netting $750,000+ per week in operational savings.
Leading Pharmaceutical Company Eliminates Costly Errors & Re-Submissions by Unifying its ECMs
For a global pharmaceutical company, using multiple, disparate document-management systems resulted in costly FDA submission errors and loss of valuable intellectual property (IP). For every delay and resubmission they faced, the company lost $250,000 and was delayed an additional 30-60 days—so there was a steep business costs associated with simply maintaining the status quo.
Additionally, critical files weren’t readable, and the company’s disparate suite of solutions couldn’t handle the massive volume of email sent and received on a daily basis. Discover how this enterprise was able to unify their ECMs, eliminate resubmissions, and decommission costly and insufficient solutions by implementing Adlib.